Israel's BrainStorm says stem cell drug benefits ALS patients

April 21, 2015 10:31 AM

20 0

TEL AVIV (Reuters) - Israel's BrainStorm Cell Therapeutics said a mid-stage clinical trial of its adult stem cell treatment showed a "statistically significant" effect in patients with amyotrophic lateral sclerosis (ALS).

According to the ALS Association, 5,600 people in the United States are diagnosed each year with the neurodegenerative disease, also known as Lou Gehrig's Disease, which has severely disabled British physicist Stephen Hawking.

Read more

To category page